Healthcare Business - Page 2

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Eli Lilly and Co. (NYSE: LLY) announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the Fifth Annual Maui Derm NP+PA Fall meeting. ...
Read Full Story »

Health Care Insurance and Health Care REITs See Safety Trade During Market Panic

On days when the main stock market indexes are trading sharply lower, it is interesting to see what stocks and sectors are trading higher on the day. The Dow Jones ...
Read Full Story »

Johnson & Johnson May Have Just Dodged a Big Opioid Bullet

Johnson & Johnson (NYSE: JNJ) surprised investors on Wednesday morning by announcing a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial. While this in and ...
Read Full Story »

FDA Accepts for Review the Newest Treatment for C Diff

Merck & Co. Inc. (NYSE: MRK) has just announced that the U.S. Food and Drug Administration (FDA) accepted a couple New Drug Applications (NDAs) for review. Specifically, the FDA accepted ...
Read Full Story »

Baird Has 3 Top Biotech Picks With Huge Upcoming Potential Catalysts

Needless to say, the biotech world has had a difficult 2019, with the SPDR S&P Biotech ETF (NYSE: XBI) down 20% from highs posted in April. Even the biggest and ...
Read Full Story »

Would Stryker Be Better Off Buying Conformis?

Conformis Inc. (NASDAQ: CFMS) shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker Corp. (NYSE: SYK) to ...
Read Full Story »

Unusual Settlement Deal Proposed for Opioid Lawsuits

Five pharmaceuticals makers are proposing an unusual method for settling hundreds of the more than 2,500 lawsuits facing drugmakers that made and sold opioid painkillers. The five companies want to ...
Read Full Story »

Are Biotechs the Next Target for Cyber Criminals?

After Minerva Neurosciences Inc. (NASDAQ: NERV) announced that it was the victim of a cyberattack, its shares dropped sharply on Tuesday. Minerva also provided an update on its clinical trials. ...
Read Full Story »

Major Duchenne Muscular Dystrophy Trial Is Ready to Launch

Catabasis Pharmaceuticals Inc. (NASDAQ: CATB) has announced that it completed the enrollment for its late-stage Duchenne muscular dystrophy (DMD) study. Specifically, the enrollment is for the Phase 3 PolarisDMD trial ...
Read Full Story »

Even Moderate Weight Loss Can Stop Type 2 Diabetes

New research shows that for those afflicted with type 2 diabetes, losing even 15 or 20 pounds can send the disease into remission. Some 400 million people worldwide have type ...
Read Full Story »

Why This Successful Bladder Cancer Study May Not Be Enough

Immunomedics Inc. (NASDAQ: IMMU) shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual ...
Read Full Story »

Ovarian Cancer Study Suffers Big Setback

ImmunoGen Inc. (NASDAQ: IMGN) has released data from its late-stage ovarian cancer study at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain. Specifically, this data comes ...
Read Full Story »

Are Dova Pharma Investors Getting the Most Out of This Acquisition?

Dova Pharmaceuticals Inc. (NASDAQ: DOVA) shares jumped on Monday after the firm announced that it would be acquired by Swedish Orphan Biovitrum, or Sobi. Through this acquisition, Sobi is looking ...
Read Full Story »

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

With the final quarter of 2019 beginning next Tuesday, many investors are taking a long hard look at their portfolios and trying to make some adjustments. While the end of ...
Read Full Story »

Good News for Teens Suffering Atopic Dermatitis

Pfizer Inc. (NYSE: PFE) has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib in patients aged 12 and older with moderate to severe atopic dermatitis ...
Read Full Story »